CAV1 and metabolic dysfunction-associated steatotic liver disease: To investigate the role of CAV1 in the progression of MASLD, we assessed its expression in two cohorts of patients with MASLD obtained from the Gene Expression Omnibus Datasets (GSE207310 and GSE126848).